DAA2357 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
106.0% Increase Gene Expression Level |
|
DAA1440 |
transcription factor CP2-like 1 |
Molecular |
hippocampus |
Mouse |
Tcfcp2l1 |
5.0% Increase Gene Expression Level |
|
DAA1441 |
transcription factor Dp 1 |
Molecular |
hippocampus |
Mouse |
Tfdp1 |
2.0% Increase Gene Expression Level |
|
DAA1389 |
N-acetyltransferase 15 (GCN5-related, putative) |
Molecular |
hippocampus |
Mouse |
Nat15 |
1.0% Decrease Gene Expression Level |
|
DAA2036 |
Neural stem cell pool declines |
Physiological |
hippocampus |
Mouse |
— |
— |
|
DAA2358 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
135.4% Increase Gene Expression Level |
|
DAA1391 |
acyl-CoA synthetase short-chain family member 1 |
Molecular |
hippocampus |
Mouse |
Acss1 |
2.0% Decrease Gene Expression Level |
|
DAA1426 |
RNA binding motif protein 3 |
Molecular |
hippocampus |
Mouse |
Rbm3 |
3.0% Increase Gene Expression Level |
|
DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
DAA2359 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
hippocampus |
Human |
HLA-DRA |
324.5% Increase Gene Expression Level |
|
DAA2216 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
hippocampus |
Human |
MYD88 |
59.3% Increase Gene Expression Level |
|
DAA2217 |
S100 calcium binding protein A8 increases with age |
Molecular |
hippocampus |
Human |
S100A8 |
1115.4% Increase Gene Expression Level |
|
DAA1408 |
dual specificity phosphatase 6 |
Molecular |
hippocampus |
Mouse |
Dusp6 |
3.0% Decrease Gene Expression Level |
|
DAA1406 |
DNA segment, human D4S114 |
Molecular |
hippocampus |
Mouse |
D0H4S114 |
5.0% Decrease Gene Expression Level |
|
DAA2251 |
interleukin 18 (interferon-gamma-inducing factor) increases with age |
Molecular |
hippocampus |
Human |
IL18 |
68.9% Increase Gene Expression Level |
|
DAA1392 |
zinc finger and BTB domain containing 16 |
Molecular |
hippocampus |
Mouse |
Zbtb16 |
2.0% Increase Gene Expression Level |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA1407 |
dimethylarginine dimethylaminohydrolase 2 |
Molecular |
hippocampus |
Mouse |
Ddah2 |
3.0% Decrease Gene Expression Level |
|
DAA1432 |
S100 protein, beta polypeptide, neural |
Molecular |
hippocampus |
Mouse |
S100b |
4.0% Increase Gene Expression Level |
|
DAA1394 |
annexin A2 |
Molecular |
hippocampus |
Mouse |
Anxa2 |
8.0% Increase Gene Expression Level |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA1981 |
Selective increase in oxidative damage and decrease in antioxidant function during aging in the substantia nigra |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1083 |
Dipeptidyl-peptidase 8 |
Molecular |
pons |
Human |
DPP8 |
Increase DNA Methylation |
|